Product NDC: | 55566-0302 |
Proprietary Name: | ACTHREL |
Non Proprietary Name: | corticorelin ovine triflutate |
Active Ingredient(s): | 100 ug/2mL & nbsp; corticorelin ovine triflutate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55566-0302 |
Labeler Name: | Ferring Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020162 |
Marketing Category: | NDA |
Start Marketing Date: | 19960523 |
Package NDC: | 55566-0302-1 |
Package Description: | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) |
NDC Code | 55566-0302-1 |
Proprietary Name | ACTHREL |
Package Description | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) |
Product NDC | 55566-0302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | corticorelin ovine triflutate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960523 |
Marketing Category Name | NDA |
Labeler Name | Ferring Pharmaceuticals Inc. |
Substance Name | CORTICORELIN OVINE TRIFLUTATE |
Strength Number | 100 |
Strength Unit | ug/2mL |
Pharmaceutical Classes |